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http://www.biomedcentral.com/1472-6882/12/90RESEARCH ARTICLE Open AccessHepatoprotective activity of Sonchus asper against
carbon tetrachloride-induced injuries in male rats:
a randomized controlled trial
Rahmat A Khan1,2*†, Muhammad R Khan2†, Sumaira Sahreen2,3† and Naseer Ali Shah2†Abstract: Background: Sonchus asper (SAME) is used as a folk medicine in hepatic disorders. In this study, the
hepatoprotective effects of the methanol extract of SAME was evaluated against carbon tetrachloride (CCl4)-induced
liver injuries in rats.
Methods: To evaluate the hepatoprotective effects of SAME, 36 male Sprague–Dawley rats were equally divided into 6
groups. Rats of Group I (control) were given free access to approved feed and water. Rats of Group II were injected
intraperitoneally with CCl4 (3 ml/kg) as a 30% solution in olive oil (v/v) twice a week for 4 weeks. Animals of Groups III
(100 mg/kg) and IV (200 mg/kg) received SAME, whereas those of Group V were given silymarin via gavage (100 mg/
kg) after 48 h of CCl4 treatment. Group VI received SAME (200 mg/kg) twice a week for 4 weeks without CCl4
treatment. Various parameters, such as the serum enzyme levels, serum biochemical marker levels, antioxidant enzyme
activities, and liver histopathology were used to estimate the hepatoprotective efficacy of SAME.
Results: The administration of SAME and silymarin significantly lowered the CCl4-induced serum levels of hepatic marker
enzymes (aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase), cholesterol, low-density
lipoprotein, and triglycerides while elevating high-density lipoprotein levels. The hepatic contents of glutathione and
activities of catalase, superoxide dismutase, glutathione peroxidase, glutathione S-transferase, and glutathione reductase
were reduced. The levels of thiobarbituric acid-reactive substances that were increased by CCl4 were brought back to
control levels by the administration of SAME and silymarin. Liver histopathology showed that SAME reduced the
incidence of hepatic lesions induced by CCl4 in rats.
Conclusion: SAME may protect the liver against CCl4-induced oxidative damage in rats.
Keywords: Carbon tetrachloride, Sonchus asper, Liver histopathology, Antioxidant, Lipid peroxidation, Liver enzymesBackground
Hepatotoxicity is the most widespread pathology world-
wide, representing up to 83% of all cases. Hepatitis, viral
infections, food additives, alcohol, toxic industrial che-
micals, and air and water pollutants are the major risk
factors of liver toxicity. There is increasing evidence that
free radicals and reactive oxygen species play a crucial
role in various steps that initiate and regulate the pro-
gression of liver diseases independently of the original
agent [1]. Carbon tetrachloride (CCl4) is a potent* Correspondence: Rahmatgul_81@yahoo.com
†Equal contributors
1Department of Biotechnology, Faculty of Biological Sciences, University of
Science and Technology Bannu, Khyber Pakhtunkhwa, Pakistan
2Department of Biochemistry, Faculty of Biological Sciences, Quaid-I-Azam
University Islamabad, Islamabad, Pakistan
Full list of author information is available at the end of the article
© 2012 Khan et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orenvironmental hepatotoxin [2] that, in addition to hep-
atic problems, causes dysfunction of the kidneys, lungs,
testis, brain, and blood by generating free radicals [3,4].
CCl4 requires bioactivation in phase I of the cyto-
chrome P450 system to form the reactive metabolic
trichloromethyl radical (•CCl3) and trichloromethyl per-
oxy radical (•OOCCl3). These free radicals can bind with
polyunsaturated fatty acids to produce alkoxy (R•) and
peroxy radicals (ROO•) that, in turn, generate lipid per-
oxides that are highly reactive, change enzyme activity,
and finally induce injury or necrosis with corresponding
health problems [5,6].
CCl4 is known to decrease glutathione (GSH) of phase
II enzymes and reduce antioxidant enzymes and sub-
strates to induce oxidative stress, which is an important
factor in acute and chronic injuries in various tissues [7,8].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ities of antioxidant enzymes, leading to hepatic injury [9].
The depletions of these antioxidant enzymes occur sec-
ondary to the controlling action against peroxy radicals
produced by CCl4. Reactive oxygen species cause oxidative
DNA damage in the form of DNA adducts, genetic muta-
tion, strand breakage, and chromosomal alterations [10].
Some recent investigations revealed that free radicals
increased the number of argyrophilic nucleolar organizer
regions (AgNORs) and activity of telomerase in kidney tis-
sues [11], caused depletion of cytochrome P450 2E1, and
increased the 8-hydroxyl-2 deoxyguanosine concentration
[12]. DNA fragmentation causes p53 gene expression,
blocks the cell cycle, and gives additional time to repair
DNA. However, severe DNA damage triggers apoptosis
[13].
Sonchus asper (SAME), locally called Mahtari, is a com-
mon herb that grows wildly and abundantly in open fields.
Chemical studies of SAME indicated a high content of vita-
min C (ascorbic acid) [14], carotenoids, and type ω-3 fatty
acids [15,16]. Phenolic compounds, which are secondary
metabolites in plants, are one of the most widely oc-
curring groups of phytochemicals that exhibit a wide
range of physiological properties, such as antioxidant,
anti-allergenic, anti-microbial, anti-artherogenic, anti-
thrombotic, anti-inflammatory, vasodilatory, and cardiopro-
tective effects [17,18]. Chemical characterization of SAME
has shown the presence of ionone derivatives of glycosides
and sesquiterpene lactone glycosides [19]. These bioactive
compounds have been shown to possess strong antioxidant
and anti-inflammatory properties [20]. SAME has diuretic,
refrigerant, sedative, and antiseptic properties that are used
in the treatment of cough, bronchitis, and asthma [21] as
well as kidney inflammation [22], and its decoction is used
in the treatment of impotence (erectile dysfunction) [23].
With increasing recognition of herbal medicine and phy-
totherapy as alternative forms of health care, the objectives
of this study were to evaluate the antioxidant and hepato-
protective properties of SAME against CCl4-induced hep-
atic injuries in Sprague–Dawley male rats.
Methods
Chemicals
Reduced glutathione (GSH), oxidized glutathione (GSSG),
glutathione reductase, gamma-glutamyl p-nitroanilide, gly-
cylglycine, bovine serum albumin (BSA), 1,2-dithio-bis
nitro benzoic acid (DTNB), 1-chloro-2,4-dinitrobenzene
(CDNB), reduced nicotinamide adenine dinucleotide
phosphate (NADPH), CCl4, flavine adenine dinucleotide
(FAD), glucose-6-phosphate, Tween-20, 2,6-dichlorophe-
nolindophenol, thiobarbituric acid (TBA), picric acid,
sodium tungstate, sodium hydroxide, trichloroacetic acid
(TCA) and perchloric acid (PCA) were purchased from
Sigma Chemicals Co. USA.Plant collection
Plants of Sonchus asper at maturity were collected from
Wah Cantt, District Rawalpindi (Pakistan) during June,
2010. Plants were identified by Prof. Dr. Mir Ajab Khan
(Dean Faculty of Biological Sciences, Quaid-i-Azam Uni-
versity Islamabad, Pakistan) and a specimen was submit-
ted vide #147 at Herbarium of Pakistan (Quaid-i-Azam
University Islamabad, Pakistan). Whole plant (leaves,
stem, flowers, roots and seeds) were shades dried at
room temperature for two weeks, chopped, ground
mechanically of 1 mm mesh size.
Preparation of plant extracts
Five kg powder of Sonchus asper was socked in 10 liters of
methanol with shaking a number of times. After a week of
socking the extract was filtered through Whatmann filter
paper # 45, and the filtrate was evaporated through rotary
vacuum evaporator to get 407 g of methanol crude extract
(SAME), stored at 4°C until further use.
Animals
Six week old, 36 Sprague Dawley male rats (190–200 g)
were provided by National Institute of Health Islamabad
and were kept in ordinary cages at room temperature of
25± 3°C with a 12 h dark/light cycle. They were allowed
to standard laboratory feed and water. The study protocol
was approved by Ethical Committee of Quaid-i-Azam
University Islamabad for laboratory animal feed and care.
Experimental design
To study the antioxidant effects of SAME, rats were
equally divided into 6 groups (6 rats). Group 1 received
only vehicles olive oil; (1 ml/kg bw) and DMSO (1 ml/kg
bw) and have free access to food materials. Animals of
group II, III and IV received CCl4 3 ml/kg (30% in olive
oil; v/v) intraperitoneally twice a week for four weeks.
Group II was treated with CCl4 only while group III
(100 mg/kg bw) and IV received (200 mg/kg bw) SAME
(intragastric, in DMSO) after 48 h of CCl4. Rats of group
V were given silymarin (intragastric, in DMSO) at a dose
of 100 mg/kg bw, after 48 h of CCl4 treatment. Animals
of a group VI were given SAME (200 mg/kg bw) intra-
gastrically. Experimental period was of four weeks. After
24 h of the last treatment, all the animals were weighted,
sacrificed; collected their blood, weighted and perfuse a
liver in ice-cold saline solution. Half of liver tissues was
treated with liquid nitrogen for further enzymatic and
DNA damage analysis while the other portion was pro-
cessed for histology.
Assessment of serum markers
Serum analysis of various liver marker enzymes such as ala-
nine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALP), lactate dehydrogenase
Khan et al. BMC Complementary and Alternative Medicine 2012, 12:90 Page 3 of 8
http://www.biomedcentral.com/1472-6882/12/90(LDH) and biochemical markers; level of total cholesterol
(TC), high-density lipoproteins (HDL), low-density lipopro-
teins (LDL) and triglycerides (TG) were estimated by using
standard AMP diagnostic kits (Stattogger Strasse 31b 8045
Graz, Austria).
Assessment of antioxidant status
70 mg of liver tissue was homogenized in 10 volumes of
100 mmol KH2PO4 buffer containing 1 mmol EDTA
(pH 7.4) and centrifuged at 12,000 × g for 30 min at 4°C.
The supernatant was collected and used for determin-
ation of antioxidant status as described below using con-
centration of protein estimated following the method of
Lowry et al. [24]. Antioxidant status, including activity
of catalase [25], superoxide dismutase [26], glutathione-
S-transferase assay [27], glutathione reductase [28],
glutathione peroxidase [29], reduced glutathione assay
[30] and lipid peroxidation assay [31] were performed
on various hepatic samples.
DNA fragmentation% assay
DNA fragmentation assay was conducted using the pro-
cedure of Wu et al. [32] with some modifications. The
liver tissue (50 mg) was homogenized in 10 volumes of a
TE solution pH 8.0 (5 mmol Tris–HCl, 20 mmol EDTA)
and 0.2% triton X-100. 1.0 ml aliquot of each sample
was centrifuged at 27,000 × g for 20 min to separate the
intact chromatin (pellet, B) from the fragmented DNA
(supernatant, T). The pellet and supernatant fractions
were assayed for DNA content using a freshly prepared
DPA (Diphenylamine) solution for reaction. Optical
density was read at 620 nm with (SmartSpecTM Plus
Spectrophotometer catalog # 170–2525) spectrophotom-
eter. The results were expressed as an amount of % frag-
mented DNA by the following formula;
%Fragmented DNA ¼ T 100=ðTþ BÞTable 1 Effect of SAME on liver function test in rat
Treatment ALT AST
(U/L) (U/L)
Control 52. ± 2.12++ 76± 2.
3 ml/kg CCl4 111 ± 3.42** 234.0 ±
100 mg/kg SAME+CCl4 91 ± 3.23**++ 136± 4
200 mg/kg SAME+CCl4 56 ± 1.35++ 97.5 ±
100 mg/kg Silymarin + CCl4 58 ± 2.68++ 102.3 ±
200 mg/kg SAME alone 50 ± 2.14++ 75.5 ±
Mean± SE (n = 6 number).
** Significance from the control group at P< 0.01 probability level.
++ Significance from the CCl4 group at P< 0.01 probability level.AgNORs count
Silver staining technique was used according to the
Trere et al. [33]. The AgNORs technique was performed
on dried slides as follows; unstained fixed slides were
dewaxed by dipping for 3 minutes in xylene. After
complete removal of wax, the slides were hydrated in de-
creasing ethanol concentration (90, 70 and 50%) and
washed in distilled water for 10 min and dried in an
oven. After drying slides were treated with one drop of
colloidal solution (2% gelatin and 1% formic acid) and
two drops of 50% AgNO3 solution on the slide and incu-
bated at 35°C for about 8–12 min. The progressive stain-
ing was followed under a microscope to get golden
colored nuclei and brown/black NORs. Then, the slide
was washed in distilled water, treated for 1 min with 1%
sodium thiosulphate at room temperature to stop the re-
action, and washed in tap water. The cells were exam-
ined under a light microscope at 100 ×magnifications
and number of AgNORs was counted per cell.
Histopathological studies
For microscopic evaluation, liver were fixed in a fixative
(absolute ethanol 60%, formaldehyde 30%, and glacial
acetic acid 10%) and embedded in paraffin, sectioned at
4 μm and subsequently stained with hematoxylin/eosin.
Sections were studied under a light microscope (DIA-
LUX 20 EB) at 40 and 100 magnifications. Slides of all
the treated groups were studied and photographed.
Statistical analysis
Data were expressed as mean and standard error (SE)
and ANOVA test were used to analyze the difference
among various treatments, with least significance differ-
ence (LSD) at 0.05 and 0.01 as a level of significance.
SPSS ver. 14.0 (Chicago, IL, USA) and Microsoft Excel
2007 (Roselle, IL, USA) were used for the statistical and
graphical evaluations.ALP LDH (nmol/min/
(U/L) mg protein)
74++ 198 ± 3.93++ 48.3 ± 2.38++
4.27** 470.3 ± 6.49** 77.6 ± 2.46**
.91**++ 347.7 ± 10.7**++ 66± 3.76**+
2.90**++ 217.8 ± 3.91*++ 53± 2.61++
4.99**++ 227.5 ± 3.89**++ 50± 4.08++
3.26++ 195.3 ± 4.11++ 46± 2.38++









Control 7.8 ± 0.45++ 6.1 ± 0.25++ 3.6 ± 0.21++ 2.48 ± 0.32++
3 ml/kg CCl4 11.3 ± 0.58** 11.2 ± 0.23** 2.8 ± 0.18** 8.4 ± 0.17**
100 mg/kg SAME+CCl4 9.2 ± 0.41**++ 7.7 ± 0.21**++ 3.08 ± 0.09**++ 4.2 ± 0.21**++
200 mg/kg SAME+CCl4 8.3 ± 0.18++ 6.4 ± 0.27++ 3.5 ± 0.20++ 2..53 ± 0.35++
100 mg/kg Silymarin + CCl4 7.2 ± 0.44++ 5.7 ± 0.19++ 3.7 ± 0.21++ 2.21 ± 0.31++
200 mg/kg SAME alone 7.5 ± 0.44++ 5.8 ± 0.44++ 3.75 ± 0.21++ 2.36 ± 0.12++
Mean± SE (n = 6 number).
** Significance from the control group at P< 0.01 probability level.
++ Significance from the CCl4 group at P< 0.01 probability level.
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Effect of SAME on alanine aminotransferase, aspartate
aminotransferase, alkaline phosphatase, and lactate
dehydrogenase
The levels of certain serum marker enzymes, including ala-
nine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALP), and lactate dehydrogen-
ase (LDH), are highly susceptible to hepatotoxins. They
serve as markers of liver damage and oxidative stress, which
promote the release of aminotransferases from hepatocytes
into the bloodstream. The protective effects of SAME and
silymarin on the activity of liver serum marker enzymes are
shown in Table 1. Administration of CCl4 to rats signifi-
cantly (P< 0.01) increased the activity of liver serum mar-
ker enzymes compared with controls. The levels of ALT,
AST, ALP, and LDH were significantly (P< 0.01) and dose-
dependently restored by treatment with SAME and sily-
marin compared with the CCl4 group. However, non-
significant variation was observed by SAME treatment
alone compared with the control group.
Effect of SAME on triglycerides, total cholesterol, high-
density lipoprotein, and low-density lipoprotein
The effect of SAME on the cholesterol profile is
shown in Table 2. Administration of CCl4 significantlyTable 3 Effect of SAME on antioxidant defense system in rat
Treatment CAT SOD GST
(U/min) (U/mg protein) nmol/
Control 4.8 ± 0.10++ 22.7 ± 1.18++ 192± 2
3 ml/kg CCl4 2.9 ± 0.06** 11.9 ± 0.38** 104± 2
100 mg/kg SAME+CCl4 4.04 ± 0.09++ 16.2 ± 0.38*++ 142± 2
200 mg/kg SAME+CCl4 4.8 ± 0.125++ 20.4 ± 0.37++ 190± 2
100 mg/kg Silymarin + CCl4 4.9 ± 0.116++ 22.9 ± 0.57++ 201± 2
200 mg/kg SAME alone 4.96 ± 0.05++ 24.7 ± 0.38++ 199± 2
Mean± SE (n = 6 number).
*, ** Significance from the control group at P< 0.05 and P< 0.01 probability level.
++ Significance from the CCl4 group at P< 0.01 probability level.(P< 0.01) increased the concentration of triglycerides,
total cholesterol, and low-density lipoprotein, but
decreased the high-density lipoprotein level compared
with the control group. The CCl4-induced alteration
of the cholesterol profile was significantly (P< 0.01)
restored with SAME treatment at both doses (100
mg/kg and 200 mg/kg) compared with the control
group. Silymarin resulted in a degree of recovery of
the cholesterol profile comparative with that achieved
with the high dose of SAME.
Effect of SAME on antioxidant and lipid peroxidation
enzymes in liver
The toxicity of CCl4 significantly decreased the liver
catalase, superoxide dismutase, GSH S-transferase,
GSH peroxidase (GSH-Px), and GSH reductase levels
of the control group (Table 3). Addition of SAME at
doses of 100 and 200 mg/kg and silymarin at 100
mg/kg reversed the decreased hepatic catalase and
superoxide dismutase levels. In particular, the high
dose of SAME (200 mg/kg) almost completely
restored the catalase and superoxide dismutase activ-
ities to the control levels. The hepatic levels of GSH
S-transferase, GSH-Px, and GSH reductase were par-
tially reversed by SAME at 200 mg/kg.liver
GR GSH-Px
min/mg protein nmol/min/mg protein nmol/min/mg protein
.49++ 127.3 ± 10.5++ 84.2 ± 5.9++
.4** 62.33 ± 9.28** 46 ± 3.6**
.6*++ 90.2 ± 11.3*++ 61± 6.6*++
.9++ 112.3 ± 6.5++ 75± 4.2++
.5++ 134.3 ± 5.7++ 84± 4.0++
.19++ 132.3 ± 6.96++ 87± 3.5++
Table 4 Effect SAME on TBARS and GSH contents in rat
liver
Treatment GSH (μmol/g tissue) TBARS (nmol /min
/mg protein)
Control 1.23 ± 0.02++ 28.33 ± 1.12++
3 ml/kg CCl4 0.60 ± .012** 52.17 ± 2.61**
100 mg/kg SAME+CCl4 1.09 ± 0.02**++ 43.0 ± 2.76**++
200 mg/kg SAME+CCl4 1.81 ± 0.50++ 30.0 ± 1.77++
100 mg/kg Silymarin + CCl4 1.27 ± 0.013++ 27.17 ± 1.22++
200 mg/kg SAME alone 1.25 ± 0.018++ 27.50 ± 1.82++
Mean± SE (n = 6 number).
** Significance from the control group at P< 0.01 probability level.
++ Significance from the CCl4 group at P< 0.01 probability level.
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substances in liver
The hepatic level of GSH was decreased while the
thiobarbituric acid-reactive substances (TBARS) were
increased in the CCl4-treated animals compared with
the controls (Table 4). The CCl4-induced changes in
these parameters were dose-dependently diminished
by oral addition of various doses of SAME and sily-
marin. No significant changes in GSH or TBARS
were found with SAME alone compared with control
rats.
Effect of SAME on body weight, absolute liver weight,
relative liver weight, % DNA fragmentation, and AgNORs
in rat liver
The NORs stained by silver ion and the AgNOR-
associated proteins, called AgNOR proteins, play a sig-
nificant role in differentiation of tumor cells from nor-
mal cells, as shown along with increases in liver
weight, relative liver weight, % DNA fragmentation,
and % increases in body weight (Table 5). Administra-
tion of CCl4 significantly (P< 0.01) amplified the num-
ber of NORs per cell, increased the liver weight,
increased the relative liver weight, increased the %






Control 35.00 ± 0.87++ 7.0 ± 0.23++
3 ml/kg CCl4 24.52 ± 0.92** 8.6 ± .89**
100 mg/kg SAME+CCl4 30.08 ± 0.81**++ 7.4 ± 0.10*++
200 mg/kg SAME+CCl4 35.64 ± 0.73++ 7.04 ± 0.23++
100 mg/kg Silymarin + CCl4 36.82 ± 0.69++ 6.83 ± 0.07++
200 mg/kg SAME alone 35.72 ± 0.70++ 6.8 ± 0.12++
Mean± SE (n = 6 number).
*, ** Significance from the control group at P< 0.05 and P< 0.01 probability level.
++ Significance from the CCl4 group at P< 0.01 probability level.body weight compared with untreated rats. However,
50 mg/kg of silymarin and various doses of SAME
augmented the CCl4-induced intoxication and signifi-
cantly (P< 0.01) recovered the NORs per cell, body
weight, liver weight, and relative liver weight. The %
DNA fragmentation was markedly (P< 0.01) decreased.
Effect of SAME on liver histology
Histopathological investigation results showed significant
correlations with the biochemical study results. The
graded observations of hematoxylin and eosin-stained sec-
tions are shown in Table 6 and Figure 1. Administration of
CCl4 caused marked increases in fatty changes and cellular
hypertrophy; cellular aggregation caused benign tumor
formation, and inflammatory cell infiltration, ballooning,
and congestion of blood vessels were observed compared
with controls. Administration of SAME attenuated the
hepatic injuries with little or no fatty changes; dilation of
blood vessels and uniform hepatocyte morphology nearly
identical to that of the control group was found. Similar
observations were recorded after silymarin treatment.
These results suggest a positive correlation of SAME and
silymarin with the activities of serum aminotransferases
and hepatic lipid peroxidation and hepatic antioxidant
enzymes.
Discussion
A number of drugs, toxic industrial chemicals, and viral
infections have been reported to cause severe hepatic in-
juries, which are sometimes difficult to manage by medical
therapies. It is important to evaluate plant extracts that
can be used for improved treatment of hepatic failure
caused by severe oxidative stress and necrosis [34]. Estima-
tion of serum enzymes is a useful quantitative marker of
the extent and type of hepatocellular damage. Increases in
serum AST, ALT, ALP, and LDH levels have been attribu-
ted to damaged structural integrity of the liver, because
these are cytoplasmic in location and are released into the
circulation after autolytic breakdown or cellular necrosisweight, and % DNA fragmentation and AgNORs in rat
Relative liver weight





0.07 ± 0.002++ 2.0 ± 0.33++ 5.33 ± 2.46++
0.86 ± .0016** 6.4 ± .29** 22.50 ± 3.68**
0.074± 0.001*++ 3.5 ± 0.18**++ 6.67 ± 2.08++
0.070± 0.0023++ 2.14 ± 0.23++ 5.67 ± 3.12++
0.068± 0.007++ 1.9 ± 0.17**++ 4.67 ± 2.23++
0.068± 0.011++ 1.96 ± 0.12++ 5.50 ± 3.2++
Table 6 Effects of SAME on histology of liver






Control - - - -
3 ml/kg CCl4 +++ ++ ++ +++
100 mg/kg SAME+CCl4 - −/+ - −/+
200 mg/kg SAME+CCl4 - - - -
100 mg/kg Silymarin + CCl4 - - - -
200 mg/kg SAME alone - - - -
-, normal; +/−, mild; ++, medium; +++, severe disruption.
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LDH into the circulation indicates severe damage to hep-
atic tissue membranes during CCl4 intoxication [36]. The
reversal of increased serum enzymes in CCl4-induced liver
damage by SAME may occur secondary to prevention of
leakage of intracellular enzymes by the membrane
stabilization and antioxidant activity of SAME; this was
supported by the histological results in the present study.
Thus, the anti-lipid peroxidation and/or adaptive nature of
the systems brought about by SAME acted against the
damaging effects of free radicals produced by CCl4. Similar
hepatoprotective effects have been described for S. arvensis
[37]. High levels of serum cholesterol, low-density lipopro-
tein, and triglycerides and lower concentrations of high-
density lipoprotein were induced with CCl4 in rats, con-
sistent with results of other studies [36,38,39].Figure 1 (a) Hemotoxylin and Eosin-stained liver section of control ra
changes, cellular hypertrophy, degeneration of the lobular architectu
Liver section of CCl4 + SAME showing less injuries (d) Liver section ofCatalase, superoxide dismutase, and GSH-Px constitute a
“mutually supportive team” of antioxidant defenses and
play a key role in detoxification of free radicals [40,41]. Ad-
ministration of CCl4 into rat livers increased lipid peroxida-
tion, resulting in accumulation of superoxide radicals and
consequently decreased their activities in the liver [42]. Our
data revealed that CCl4 treatment significantly decreased
the activities of catalase, superoxide dis mutase, GSH-Px,
and GSH reductase in liver tissues. Co-administration of
SAME markedly decreased the toxicity of CCl4 and enzym-
atic activities. Ameliorating effects of different plant
metabolites on these enzymes against the toxicity of CCl4
have also been documented [42]. TBARS is a major reactive
aldehyde resulting from the peroxidation of polyunsatur-
ated fatty acids. It is a useful indicator of tissue damage, in-
cluding a series of chain reactions [43]. High hepatic levelst (b) Liver section of CCl4 treated rats showing marked fatty
re and blood vessel congestion with disturbed epithelium (c)
CCl4 + Silymarin showing less injuries.
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sive oxidative damage to liver tissues. Restoration of nitrite
and TBARS with SAME may suggest a role of SAME in
controlling various pathological conditions, including oxi-
dative stress [20]. Histopathologic results in the present
study revealed that CCl4 induces extensive fatty change,
blood vessel congestion, cellular hypertrophy, necrotic foci,
destruction of the lobular architecture, fibrosis, and nuclear
degeneration in some areas, all of which were markedly
diminished by induction of SAME. These data are in good
agreement with the results of the serum aminotransferase
activities and hepatic lipid peroxidation levels. Similar pro-
tection was evident with respect to necrosis, which is a
more severe form of injury, in that it was minimized by
treatment with SAME. Other studies on the protective
effect of Carissa opaca extract against CCl4-induced hep-
atotoxicity in rats have revealed similar findings that are in
agreement with the present findings [44].
Conclusions
This study evaluated the pharmacological use of SAME
against CCl4 induced liver injuries. Low lipid peroxidation
and increased activities of various antioxidant enzymes in-
dicate that SAME is able to protect various pathological
conditions, including oxidative stress. It is suggested, to iso-
late the antioxidants from SAME that could be utilized as
therapeutics against the oxidative diseases.
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